Arbor Biotechnologies Comes Out of Stealth Mode Post author:Sam Post published:March 15, 2018 Post category:BioPharma Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round. Source: BioSpace You Might Also Like There???s Lots of Work at the Top 10 World???s Largest Pharmaceutical Companies August 30, 2017 Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection) July 23, 2017 Stryker And AlloSource Announce Collaboration To Distribute Biologics For Use In Sports Medicine Procedures May 18, 2017
Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection) July 23, 2017
Stryker And AlloSource Announce Collaboration To Distribute Biologics For Use In Sports Medicine Procedures May 18, 2017